Court KOs REMS-re­lat­ed patent list­ing for Jazz nar­colep­sy drug

A Delaware dis­trict court said say­onara to a Jazz Phar­ma­ceu­ti­cals patent re­lat­ed to the dis­tri­b­u­tion sys­tem for its block­buster nar­colep­sy drug Xyrem.

The case at …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER